Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
GB00BDHSP575
Tue, 20.08.2024
JP Jenkins Ltd
20th Aug 2024
JPJ: DEST
ISIN: GB00BDHSP575
Destiny Pharma plc
("Destiny Pharma" or "the Company")
Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascular Surgery Patients.
Brighton, [ … ]
Wed, 14.08.2024
JP Jenkins Ltd
13th Aug 2024
JPJ: DEST
ISIN: GB00BDHSP575
Destiny Pharma plc("Destiny Pharma" or "the Company")
Destiny Pharma initiates research to explore XF drug potential for CF
Study to investigate the potential of XF-73 to treat MRSA infection in people with cystic fibrosis
Brighton, United Kingdom – 14 August 2024 – Destiny Pharma (JP [ … ]
Tue, 13.08.2024
JP Jenkins Ltd
13th Aug 2024
JPJ: DEST
ISIN: GB00BDHSP575
Destiny Pharma plc
("Destiny Pharma" or "the Company")
Shares now trading on JP Jenkins
London, UK, 13th Aug 2024 - Destiny Pharma plc (JPJ: DEST), a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life-threatening in [ … ]
Mon, 21.11.2022
Destiny Pharma PLC
Contact DetailsProactiveProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.comNews Source: News Direct
21.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
Mon, 21.11.2022
Destiny Pharma PLC
Contact DetailsProactiveProactive UK Ltd+44 20 7989 0813uk@proactiveinvestors.comNews Source: News Direct
21.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.